After a stellar 3x rise since the March 23 levels of this year, at the current price of around $170 per share we believe Novocure stock, a company working on an innovative cancer treatment alternative using electric fields, has reached its near-term potential. NVCR stock has rallied...
After a stellar 3x rise since the March 23 levels of this year, at the current price of around $170 per share we believe Novocure stock, a company working on an innovative cancer treatment alternative using electric fields, has reached its near-term potential. NVCR stock has rallied...
Share this Article
Recommended